FindTrial
Sign In

Awareness of Anti-Seizure Medicines and Barriers to Their Use Among People with Epilepsy at AIIMS, New Delhi

A mixed-methods study to assess Anti-Seizure Medications awareness and to explore the barriers to medication Awareness of their prescribed Anti-seizure Medications Regimen among person with epilepsy attending Neurology clinic at AIIMS, New Delhi - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2026/05/110943
Enrollment
165
Registered
2026-05-22
Start date
Unknown
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G409- Epilepsy, unspecified

Interventions

Intervention1: Nil: Nil Intervention2: Nil: Nil Intervention3: Nil: Nil Intervention4: Nil: Nil Intervention5: Nil: Nil

Sponsors

Birme Megu
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1) Adults (18 years and older) diagnosed with epilepsy (ILAE Definition) or primary caregivers in case of patient is cognitively subnormal. 2) Currently prescribed one or more antiseizure medications. 3) Able to provide informed consent and communicate responses for the study.

Exclusion criteria

Exclusion criteria: Persons who are unwilling or unable to participate fully in the study procedures.

Design outcomes

Primary

MeasureTime frame
Among persons with epilepsy attending AIIMS outpatient adult neurology clinic: - To assess awareness regarding prescribed antiseizure medications. - To explore the barriers to medication awareness of their prescribed Anti-seizure Medications regimen. Timepoint: single time point at baseline—

Secondary

MeasureTime frame
nilTimepoint: nil—

Countries

India

Contacts

Public ContactBirme Megu

All India Institute of Medical Sciences.

pragyapathak1@gmail.com9914666115

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 11, 2026